Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
23M
-
Shares change
-
-966K
-
Total reported value, excl. options
-
$93.9M
-
Value change
-
-$6.78M
-
Put/Call ratio
-
0.9
-
Number of buys
-
46
-
Number of sells
-
-20
-
Price
-
$4.08
Significant Holders of IDERA PHARMACEUTICALS INC - COM NEW (IDRA) as of Q1 2014
81 filings reported holding IDRA - IDERA PHARMACEUTICALS INC - COM NEW as of Q1 2014.
IDERA PHARMACEUTICALS INC - COM NEW (IDRA) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 23M shares
.
Largest 10 shareholders include Broadfin Capital, LLC (3.2M shares), NATIXIS (3.15M shares), FMR LLC (2.95M shares), MILLENNIUM MANAGEMENT LLC (2.63M shares), VANGUARD GROUP INC (1.81M shares), BAKER BROS. ADVISORS LP (1.61M shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (988K shares), DIMENSIONAL FUND ADVISORS LP (972K shares), Marshall Wace LLP (572K shares), and GROUP ONE TRADING, L.P. (526K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.